AURO LABORATORIES Financial Statement Analysis
|
||
The Revenues of AURO LABORATORIES have increased by 3.99% YoY .
The Earnings Per Share (EPS) of AURO LABORATORIES has decreased by -14.04 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
AURO LABORATORIES Last 5 Annual Financial Results
[BOM: 530233]
Standalone | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹53 Cr | ₹51 Cr | ₹54 Cr | ₹44 Cr | ₹47 Cr |
Expenses | ₹49 Cr | ₹46 Cr | ₹43 Cr | ₹38 Cr | ₹40 Cr |
Operating Profit (Excl OI) | ₹4.39 Cr | ₹4.63 Cr | ₹11 Cr | ₹6.27 Cr | ₹6.99 Cr |
Other Income | ₹0.94 Cr | ₹1.09 Cr | ₹0.76 Cr | ₹0.97 Cr | ₹0.96 Cr |
Interest | ₹0.81 Cr | ₹0.83 Cr | ₹0.46 Cr | ₹0.58 Cr | ₹0.87 Cr |
Depreciation | ₹1.07 Cr | ₹1.02 Cr | ₹1.04 Cr | ₹1.02 Cr | ₹1.01 Cr |
Profit Before Tax | ₹3.45 Cr | ₹3.87 Cr | ₹11 Cr | ₹5.64 Cr | ₹6.07 Cr |
Profit After Tax | ₹2.44 Cr | ₹2.85 Cr | ₹7.18 Cr | ₹4.05 Cr | ₹4.40 Cr |
Consolidated Net Profit | ₹2.44 Cr | ₹2.85 Cr | ₹7.18 Cr | ₹4.05 Cr | ₹4.40 Cr |
Earnings Per Share (Rs) | ₹3.92 | ₹4.56 | ₹11.52 | ₹6.51 | ₹7.06 |
PAT Margin (%) | 4.62 | 5.59 | 13.23 | 9.26 | 9.40 |
ROE(%) | 7.43 | 9.47 | 28.67 | 20.84 | 28.95 |
ROCE(%) | 9.92 | 12.20 | 38.88 | 24.80 | 29.12 |
Total Debt/Equity(x) | 0.19 | 0.44 | 0.11 | 0.15 | 0.46 |
Key Financials |
||
Market Cap | : | ₹ 113.3 Cr |
Revenue (TTM) | : | ₹ 55.1 Cr |
Net Profit(TTM) | : | ₹ 7.2 Cr |
EPS (TTM) | : | ₹ 11.6 |
P/E (TTM) | : | 15.7 |
Industry Peers & Returns | 1W | 1M | 1Y |
AURO LABORATORIES | 6% | -9.2% | 179.9% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
CIPLA | 2.5% | 0.4% | 71.7% |
DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
MANKIND PHARMA | NA | NA | NA |
TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
LUPIN | 2.8% | 0% | 147.8% |
AURO LABORATORIES Revenues
[BOM: 530233]
Y-o-Y | 3.99 % |
5 Yr CAGR | 3.09 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹53 Cr | 3.99 | |
Mar2022 | ₹51 Cr | -6.24 | |
Mar2021 | ₹54 Cr | 23.89 | |
Mar2020 | ₹44 Cr | -6.48 | |
Mar2019 | ₹47 Cr | - |
AURO LABORATORIES Operating Profit
[BOM: 530233]
Y-o-Y | -5.02 % |
5 Yr CAGR | -10.97 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹4.39 Cr | -5.02 | |
Mar2022 | ₹4.63 Cr | -58.86 | |
Mar2021 | ₹11 Cr | 79.30 | |
Mar2020 | ₹6.27 Cr | -10.34 | |
Mar2019 | ₹6.99 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -8.58 % |
5 Yr CAGR | -13.63 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 8.31% | -8.58 | |
Mar2022 | 9.09% | -56.13 | |
Mar2021 | 20.72% | 44.69 | |
Mar2020 | 14.32% | -4.09 | |
Mar2019 | 14.93% | - |
AURO LABORATORIES Profit After Tax
[BOM: 530233]
Y-o-Y | -14.17 % |
5 Yr CAGR | -13.68 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹2.44 Cr | -14.17 | |
Mar2022 | ₹2.85 Cr | -60.38 | |
Mar2021 | ₹7.18 Cr | 77.11 | |
Mar2020 | ₹4.05 Cr | -7.84 | |
Mar2019 | ₹4.40 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | -17.35 % |
5 Yr CAGR | -16.27 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 4.62 % | -17.35 | |
Mar2022 | 5.59 % | -57.75 | |
Mar2021 | 13.23 % | 42.87 | |
Mar2020 | 9.26 % | -1.49 | |
Mar2019 | 9.4 % | - |
AURO LABORATORIES Earnings Per Share (EPS)
[BOM: 530233]
Y-o-Y | -14.04 % |
5 Yr CAGR | -13.68 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹3.92 | -14.04 | |
Mar2022 | ₹4.56 | -60.42 | |
Mar2021 | ₹12 | 76.96 | |
Mar2020 | ₹6.51 | -7.79 | |
Mar2019 | ₹7.06 | - |
AURO LABORATORIES Return on Capital Employed (ROCE)
[BOM: 530233]
Y-o-Y | -18.69 % |
5 Yr CAGR | -23.60 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 9.92% | -18.69 | |
Mar2022 | 12.2% | -68.62 | |
Mar2021 | 38.88% | 56.77 | |
Mar2020 | 24.8% | -14.84 | |
Mar2019 | 29.12% | - |
AURO LABORATORIES Share Price vs Sensex
Current Share Price | : | ₹182.8 |
Current MarketCap | : | ₹ 113.3 Cr |
Updated EOD on | : | Apr 16,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AURO LABORATORIES | 6% |
-9.2% |
179.9% |
SENSEX | -2.4% |
-1% |
21.3% |
AURO LABORATORIES related INDICES
You may also like the below Video Courses
FAQ about AURO LABORATORIES Financials
How the annual revenues of AURO LABORATORIES have changed ?
The Revenues of AURO LABORATORIES have increased by 3.99% YoY .
How the Earnings per Share (EPS) of AURO LABORATORIES have changed?
The Earnings Per Share (EPS) of AURO LABORATORIES has decreased by -14.04 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs